HIV/AIDS Vaccine Likely Will Not Be Available Soon
An HIV/AIDS vaccine likely will not be available in the short term, Jean-Francois Delfraissy, director of France’s National Agency for Research on AIDS and Viral Hepatitis, said on Tuesday in Dakar, Senegal, Xinhuanet reports. Read more
Board Says Stop Experimental Treatment Regimen In HIV Study
An independent Data and Safety Monitoring Board (DSMB) has determined that the experimental, once-daily antiretroviral drug regimen of emtricitabine, atazanavir and didanosine enteric-coated (ddI-EC) is inferior to a standard antiretroviral drug regimen and therefore should be discontinued in an ongoing clinical trial. Read more
Bavarian Nordic Enters Trials With HIV Multiantigen Vaccine
Bavarian Nordic has initiated a Phase I/II clinical study with its HIV vaccine candidate: MVA-BN HIV multiantigen.
Enrolment in a Phase I/II safety and immunogenicity study in 15 HIV-infected patients (CD4 counts >350 ul/ml) has begun in the United States. Read more
NIAID To Advance B-Cell Approach To HIV Vaccines
To advance underdeveloped approaches to designing a preventive HIV vaccine, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is launching a new program to foster the study of B cells, immune cells that can produce antibodies with the capacity to neutralize HIV. Read more
HIV Vaccine Formula Elicits Strong Immune Response
Today, Advanced BioScience Laboratories, Inc. (ABL) and the University of Massachusetts Medical School (UMMS) report that their unique HIV vaccine formulation was effective in eliciting strong and balanced immune responses in healthy human volunteers. Read more
Noncommunicable Diseases Now Biggest Killers
The global burden of disease is shifting from infectious diseases to noncommunicable diseases, with chronic conditions such as heart disease and stroke now being the chief causes of death globally, according to a new WHO report published today. Read more